+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Status Unknown

Phase Not Applicable
Age: 6Years - 50Years
All Genders
ID01929356

The Influence of Chest Physiotherapy on Lung Function Parameters in Primary Ciliary Dyskinesia

Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2024-07-03

29

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Primary ciliary dyskinesia (PCD) is a rare disease, caused by impairment of the motile cilia. Patients present with chronic upper and lower respiratory tract infections. The therapy is mainly supportive and based on that of cystic fibrosis. Chest physiotherapy is one of the cornerstones of the therapy, however the influence of chest physiotherapy on lung function (short term and long term) is not clear. For interpretation of longitudinal lung function data it is important to examine the short time effect of chest physiotherapy. We hypothesize that a session of chest physiotherapy improves lung function and that thus lung function tests must be performed in a standardized way.

CONDITIONS

Brief Title

Chest Physiotherapy and Lung Function in Primary Ciliary Dyskinesia

Research Team

M

Mieke Boon, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here